Predictors of optimal virological response to potent antiretroviral therapy
POWDERLY, W. G, SAAG, M. S, CHAPMAN, S, YU, G, QUART, B, CLENDENINN, N. J
Published in AIDS (London) (01.10.1999)
Published in AIDS (London) (01.10.1999)
Get full text
Journal Article
Polyglutamation of methotrexate: is methotrexate a prodrug?
CHABNER, B. A, ALLEGRA, C. J, CURT, G. A, CLENDENINN, N. J, BARAM, J, KOIZUMI, S, DRAKE, J. C, JOLIVET, J
Published in The Journal of clinical investigation (01.09.1985)
Published in The Journal of clinical investigation (01.09.1985)
Get full text
Journal Article
A phase I study of the lipophilic thymidylate synthase inhibitor Thymitaq™ (nolatrexed dihydrochloride) given by 10-day oral administration
JODRELL, D. I, BOWMAN, A, RYE, R, BYRNE, B, BODDY, A, RAFI, I, TAYLOR, G. A, JOHNSTON, A, CLENDENINN, N. J
Published in British journal of cancer (01.02.1999)
Published in British journal of cancer (01.02.1999)
Get full text
Journal Article
The Pharmacology and Clinical Use of Methotrexate
Jolivet, Jacques, Cowan, Kenneth H, Curt, Gregory A, Clendeninn, Neil J, Chabner, Bruce A
Published in The New England journal of medicine (03.11.1983)
Published in The New England journal of medicine (03.11.1983)
Get full text
Journal Article
Phase II trial of oral piritrexim in advanced, previously treated transitional cell cancer of bladder
KHORSAND, M, LANGE, J, FEUN, L, CLENDENINN, N. J, COLLIER, M, WILDING, G
Published in Investigational new drugs (01.01.1997)
Published in Investigational new drugs (01.01.1997)
Get full text
Journal Article
Phase I trial of the thymidylate synthase inhibitor AG331 as a 5-day continuous infusion
O'DWYER, P. J, LAUB, P. B, GALLO, J. M, DEMARIA, D, QIAN, M, REILLY, D, GIANTONIO, B, JOHNSTON, A. L, WU, E. Y, BAUMAN, L, CLENDENINN, N. J
Published in Clinical cancer research (01.10.1996)
Get full text
Published in Clinical cancer research (01.10.1996)
Journal Article
Phase II trial of piritrexim in metastatic melanoma using intermittent, low-dose administration
Feun, L G, Gonzalez, R, Savaraj, N, Hanlon, J, Collier, M, Robinson, W A, Clendeninn, N J
Published in Journal of clinical oncology (01.03.1991)
Published in Journal of clinical oncology (01.03.1991)
Get more information
Journal Article
Phase I study of AG2034, a targeted GARFT inhibitor, administered once every 3 weeks
ROBERTS, J. D, SHIBATA, S, PARADISO, L. J, CLENDENINN, N. J, SPICER, D. V, MCLEOD, H. L, TOMBES, M. B, KYLE, B, CARROLL, M, SHEEDY, B, COLLIER, M. A, PITHAVALA, Y. K
Published in Cancer chemotherapy and pharmacology (2000)
Published in Cancer chemotherapy and pharmacology (2000)
Get full text
Journal Article
Neoadjuvant PFL augmented by methotrexate and piritrexim followed by concomitant chemoradiotherapy for advanced head and neck cancer: A feasible and active approach
Vokes, E. E., Haraf, D. J., McEvilly, J. M., Mick, R., Kozloff, M. F., Goldman, M. D., Moran, W. J., Clendeninn, N. J., Collier, M. A., selbaum, R. R. Weich, Panje, W. R.
Published in Annals of oncology (01.01.1992)
Published in Annals of oncology (01.01.1992)
Get full text
Journal Article
Determinants of the sensitivity of human small-cell lung cancer cell lines to methotrexate
CURT, G. A, JOLIVET, J, CARNEY, D. N, BAILEY, B. D, DRAKE, J. C, CLENDENINN, N. J, CHABNER, B. A
Published in The Journal of clinical investigation (01.10.1985)
Published in The Journal of clinical investigation (01.10.1985)
Get full text
Journal Article
Pediatric phase I trial, pharmacokinetic study, and limited sampling strategy for piritrexim administered on a low-dose, intermittent schedule
ADAMSON, P. C, BALIS, F. M, MISER, J, ARNDT, C, WELLS, R. J, GILLESPIE, A, ARONSON, L, PENTA, J. S, CLENDENINN, N. J, POPLACK, D. G
Published in Cancer research (Chicago, Ill.) (01.02.1992)
Get full text
Published in Cancer research (Chicago, Ill.) (01.02.1992)
Journal Article
Phase I trial of piritrexim capsules using prolonged, low-dose oral administration for the treatment of advanced malignancies
Feun, L G, Savaraj, N, Benedetto, P, Hanlon, J, Sridhar, K S, Collier, M, Richman, S, Liao, S H, Clendeninn, N J
Published in JNCI : Journal of the National Cancer Institute (02.01.1991)
Published in JNCI : Journal of the National Cancer Institute (02.01.1991)
Get more information
Journal Article
A phase II study of piritrexim in patients with advanced squamous head and neck cancer
Uen, Wu‐Ching, Huang, Andrew T., Mennel, Robert, Jones, Stephen E., Spaulding, Monica B., Killion, Kathleen, Havlin, Kathleen, Keegan, Patricia, Clendeninn, Neil J.
Published in Cancer (15.02.1992)
Published in Cancer (15.02.1992)
Get full text
Journal Article
Oral piritrexim--a phase II study in patients with advanced soft tissue sarcoma
Schiesel, J D, Carabasi, M, Magill, G, Casper, E, Cheng, E, Marks, L, Feyzi, J, Clendeninn, N J, Smalley, R V
Published in Investigational new drugs (01.07.1992)
Published in Investigational new drugs (01.07.1992)
Get more information
Journal Article
Phase I clinical and pharmacology study of 502U83 given as a 24-h continuous intravenous infusion
Schilsky, R L, Ratain, M J, Janisch, L, Vogelzang, N J, Lucas, V S, Ravitch, J, Hohneker, J A, Clendeninn, N J, Tuttle, R L
Published in Cancer chemotherapy and pharmacology (01.01.1993)
Published in Cancer chemotherapy and pharmacology (01.01.1993)
Get more information
Journal Article
Initial clinical trial and pharmacokinetics of Thymitaq (AG337) by 10-day continuous infusion in patients with advanced solid tumors
Creaven, P J, Pendyala, L, Meropol, N J, Clendeninn, N J, Wu, E Y, Loewen, G M, Proefrock, A, Johnston, A, Dixon, M
Published in Cancer chemotherapy and pharmacology (1998)
Get full text
Published in Cancer chemotherapy and pharmacology (1998)
Journal Article
Safety, pharmacokinetics, and pharmacodynamics results from a phase I trial of BAY 86-9766 (RDEA119), a MEK inhibitor, in patients with advanced cancer
Gore, L., Lewis, K., Von Hoff, D. D., Weiss, G. J., Ramanathan, R. K., Adjei, A. A., Dy, G. K., Ma, W. W., Clendeninn, N. J., Leffingwell, D. P., Sheedy, B., Iverson, C., Miner, J. N., Shen, Z., Yeh, L., Dubowy, R. L., Jeffers, M., Rajagopalan, P., Weekes, C. D.
Published in Journal of clinical oncology (20.05.2011)
Published in Journal of clinical oncology (20.05.2011)
Get full text
Journal Article